Financial Statements

89Bio Inc

89Bio Inc (ETNB)

$25.36
0.94 (+3.85%)

Income Statement

Quarter Data

Balance Sheet Statement

Quarter Data
Year 2019 2018
Short-term debt --
Other Assets 0.040.10
Total current liabilities 4.355.61
Cash and cash equivalents 11.2393.33
Long-term debt --
Cash and short-term investments 11.2393.33
Total debt --
Inventories --
Deferred revenue --
Goodwill and Intangible Assets --
Total non-current liabilities --
Total non-current assets 0.050.23
Total liabilities 4.355.61
Total assets 11.3795.55
Other comprehensive income --
Short-term investments --
Property, Plant & Equipment Net 0.030.15
Net Debt -11.23-93.33
Investments --
Total shareholders equity 7.0289.94
Retained earnings (deficit) -16.18-73.60
Long-term investments --
Receivables --
Payables 1.510.99
Total current assets 11.3295.33

Cash Flow Statement

Quarter Data
Year 2019 2018
Operating Cash Flow -12.47-25.46
Free Cash Flow -12.51-25.60
Capital Expenditure -0.04-0.14
Depreciation & Amortization 0.010.02
Acquisitions and disposals --
Deferred income taxes -0.020.02
Investment purchases --
Accounts payables --0.52
Sales/Maturities of investments --
Change in working capital 2.630.94
Debt repayment --
Other non-cash items 1.0930.99
Investing Cash Flow -0.04-0.14
Cash at beginning of period -11.23
Stock-based compensation -0.39
Net cash flow / Change in cash 11.2682.10
Effect of forex changes on cash --
Financing Cash Flow 23.77107.70
Dividend payments --
Accounts receivables --
Cash at end of period 11.2693.34
Net cash provided by operating activities -12.47-25.46
Other working capital -89.72
Inventory --

Retained Earning Schedule

Year 2018 2019
Retained Earnings (Previous Year) --16
Net Income -16-57
Stock Dividends --
Dividend Paid --
Retained Earnings -16-74

PPE Schedule

Year 2018 2019
Gross PPE -0
Annual Depreciation 00
Capital Expenditure -0-0
Net PPE 00

Intangible and Goodwill Schedule

Year 2018 2019
Intangible and Goodwill (Previous Year) --
New Purchases --
Intangible and Goodwill --

89Bio Inc income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes 89Bio Inc FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.